Israel Englander Dice Therapeutics, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $7.47 Million - $13.5 Million	288,784 Added 106.34%	560,358 $26 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $1.6 Million - $1.98 Million	61,262 Added 29.13%	271,574 $7.78 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $668,443 - $1.43 Million	33,811 Added 19.16%	210,312 $6.56 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $46,691 - $70,645	-3,119 Reduced 1.74%	176,501 $3.58 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.